Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Enanta Pharmaceuticals stock

Learn how to easily invest in Enanta Pharmaceuticals stock.

Enanta Pharmaceuticals is a biotechnology business based in the US. Enanta Pharmaceuticals shares (ENTA) are listed on the NASDAQ and all prices are listed in US Dollars. Enanta Pharmaceuticals employs 160 staff and has a trailing 12-month revenue of around $86.2 million.

How to buy Enanta Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ENTA. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Enanta Pharmaceuticals stock price (NASDAQ: ENTA)

Use our graph to track the performance of ENTA stocks over time.

Enanta Pharmaceuticals shares at a glance

Information last updated 2023-01-25.
Latest market close$52.02
52-week range$37.59 - $79.50
50-day moving average $45.82
200-day moving average $52.22
Wall St. target price$68.22
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-5.52

Buy Enanta Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Enanta Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Enanta Pharmaceuticals price performance over time

Historical closes compared with the close of $52.02 from 2023-01-27

1 week (2023-01-24) 0.39%
1 month (2022-12-30) 11.82%
3 months (2022-10-31) 15.32%
6 months (2022-07-29) -5.68%
1 year (2022-01-31) -12.45%
2 years (2021-01-29) 8.24%
3 years (2020-01-31) 0.93%
5 years (2018-01-30) 83.61

Enanta Pharmaceuticals financials

Revenue TTM $86.2 million
Gross profit TTM $86.2 million
Return on assets TTM -19.01%
Return on equity TTM -33.79%
Profit margin -141.31%
Book value $15.46
Market capitalisation $1.1 billion

TTM: trailing 12 months

Enanta Pharmaceuticals share dividends

We're not expecting Enanta Pharmaceuticals to pay a dividend over the next 12 months.

Enanta Pharmaceuticals share price volatility

Over the last 12 months, Enanta Pharmaceuticals's shares have ranged in value from as little as $37.59 up to $79.495. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enanta Pharmaceuticals's is 0.3547. This would suggest that Enanta Pharmaceuticals's shares are less volatile than average (for this exchange).

Enanta Pharmaceuticals overview

Enanta Pharmaceuticals, Inc. , a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. .

Frequently asked questions

What percentage of Enanta Pharmaceuticals is owned by insiders or institutions?
Currently 6.382% of Enanta Pharmaceuticals shares are held by insiders and 95.406% by institutions.
How many people work for Enanta Pharmaceuticals?
Latest data suggests 160 work at Enanta Pharmaceuticals.
When does the fiscal year end for Enanta Pharmaceuticals?
Enanta Pharmaceuticals's fiscal year ends in September.
Where is Enanta Pharmaceuticals based?
Enanta Pharmaceuticals's address is: 500 Arsenal Street, Watertown, MA, United States, 02472
What is Enanta Pharmaceuticals's ISIN number?
Enanta Pharmaceuticals's international securities identification number is: US29251M1062
What is Enanta Pharmaceuticals's CUSIP number?
Enanta Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29251M106

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site